PEO-IAA

CAS No. 6266-66-6

PEO-IAA( PEO-IAA )

Catalog No. M18921 CAS No. 6266-66-6

PEO-IAA is a novel potent auxin antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 34 In Stock
25MG 51 In Stock
50MG 69 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PEO-IAA
  • Note
    Research use only, not for human use.
  • Brief Description
    PEO-IAA is a novel potent auxin antagonist.
  • Description
    PEO-IAA is a novel potent auxin antagonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PEO-IAA
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6266-66-6
  • Formula Weight
    292.31
  • Molecular Formula
    C18H14NO3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 150 mg/mL; 511.39 mM
  • SMILES
    OC(=O)C(CC(=O)c1ccccc1)c1c[nH]c2ccccc12
  • Chemical Name
    2-(1H-Indol-3-yl)-4-oxo-4-phenylbutanoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Takato S, Kakei Y, Mitsui M, Ishida Y, Suzuki M, Yamazaki C, Hayashi KI, Ishii T, Nakamura A, Soeno K, Shimada Y. Biosci Biotechnol Biochem. 2017 Apr 13:1-7.
molnova catalog
related products
  • Danshenxinkun A

    Danshenxinkun A, Danshenxinkun B and Neocryptotanshinone may intervene thrombotic diseases by adjusting the targets mainly involved in pathways of endocrine system, signal transduction, signaling molecules and interaction, cell motility, environmental adaptation and nervous system.

  • N-Formyl-Met-Ala-Ser

    N-Formyl-Met-Ala-Ser is a peptide, binds to formyl peptide receptors on neutrophils.N-Formyl-Met-Ala-Ser Peptide (fMet-Ala-Ser) binds to formyl peptide receptors on neutrophils. N-Formylmethionine-containing peptides including the most potent and known member, N-formyl-Met-Leu-Phe (FMLP or fMet-Leu-Phe) stimulate human neutrophils by a receptor-dependent mechanism.

  • Deoxyvasicinone

    Deoxyvasicinone derivatives can be considered as promising lead molecules for the development of more potent inhibitors of NEDD8-activating enzyme.